Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of D - Licensed Ly49G2+ NK cells in viral control

Journal of Immunology

Volumn 191, Issue 9, 2013, Pages 4709-4719

  Prince, Jessica ^a   Lundgren, Alyssa ^a   Stadnisky, Michael D ^a,c   Nash, William T ^a   Beeber, Amira ^b   Turner, Stephen D ^a   Brown, Michael G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c Tree Star Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LY49G2 INHIBITORY RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 DK; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY A; NATURAL KILLER CELL RECEPTOR; UNCLASSIFIED DRUG; HLA ANTIGEN CLASS 1; KLRA7 PROTEIN, MOUSE; LY ANTIGEN; NCR1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN RECOGNITION; ARTICLE; CELL EXPANSION; CELL KILLING; CONTROLLED STUDY; CYTOMEGALOVIRUS; FLOW CYTOMETRY; GENE CLUSTER; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC REGULATION; HEREDITY; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOPOTENTIATION; INFECTION CONTROL; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR PHYLOGENY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; VIRAL CLEARANCE; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS LOAD; VIRUS RESISTANCE; ANIMAL; C57BL MOUSE; GENE; GENETICS; GENOTYPE; HERPES VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MUROMEGALOVIRUS; VIROLOGY;

ANIMALS; ANTIGENS, LY; GENES, MHC CLASS I; GENOTYPE; HERPESVIRIDAE INFECTIONS; HISTOCOMPATIBILITY ANTIGENS CLASS I; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MUROMEGALOVIRUS; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A;

EID: 84886038711     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301388     Document Type: Article

References (63)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47: 187-376.
2. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
3. Orange, J. S. 2012. Unraveling human natural killer cell deficiency. J. Clin. Invest. 122: 798-801.
4. Joncker, N. T., and D. H. Raulet. 2008. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 224: 85-97.
5. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
6. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
7. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
8. Wilkinson, G. W., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, et al. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41: 206-212.
9. Kielczewska, A., M. Pyzik, T. Sun, A. Krmpotic, M. B. Lodoen, M. W. Munks, M. Babic, A. B. Hill, U. H. Koszinowski, S. Jonjic, et al. 2009. Ly49P recognition of cytomegalovirus-infected cells expressing H2-Dk and CMV-encoded m04 correlates with the NK cell antiviral response. J. Exp. Med. 206: 515-523.
10. Jarahian, M., C. Watzl, P. Fournier, A. Arnold, D. Djandji, S. Zahedi, A. Cerwenka, A. Paschen, V. Schirrmacher, and F. Momburg. 2009. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J. Virol. 83: 8108-8121.
11. Slavuljica, I., A. Busche, M. Babic, M. Mitrovic, I. Gasparovic, D. Cekinovic, E. Markova Car, E. Pernjak Pugel, A. Cikovic, V. J. Lisnic, et al. 2010. Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J. Clin. Invest. 120: 4532-4545.
12. Jackson, S. E., G. M. Mason, and M. R. Wills. 2011. Human cytomegalovirus immunity and immune evasion. Virus Res. 157: 151-160.
13. Jarahian, M., M. Fiedler, A. Cohnen, D. Djandji, G. J. Hammerling, C. Gati, A. Cerwenka, P. C. Turner, R. W. Moyer, C. Watzl, et al. 2011. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog. 7: e1002195.
14. Slavuljica, I., A. Krmpotic, and S. Jonjic. 2011. Manipulation of NKG2D ligands by cytomegaloviruses: impact on innate and adaptive immune response. Front. Immunol. 2: 85.
15. French, A. R., and W. M. Yokoyama. 2003. Natural killer cells and viral infections. Curr. Opin. Immunol. 15: 45-51.
16. Desrosiers, M.-P, A. Kielczewska, J.-C. Loredo-Osti, S. G. Adam, A. P. Makrigiannis, S. Lemieux, T. Pham, M. B. Lodoen, K. Morgan, L. L. Lanier, and S. M. Vidal. 2005. Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cellmediated innate resistance to cytomegalovirus infection. Nat. Genet. 37: 593-599.
17. Fodil-Cornu, N., J. C. Loredo-Osti, and S. M. Vidal. 2011. NK cell receptor/H2Dk-dependent host resistance to viral infection is quantitatively modulated by H2q inhibitory signals. PLoS Genet. 7: e1001368.
18. Pyzik, M., E. M. Gendron-Pontbriand, and S. M. Vidal. 2011. The impact of Ly49-NK cell-dependent recognition of MCMV infection on innate and adaptive immune responses. J. Biomed. Biotechnol. 2011: 641702.
19. Karre, K. 2008. Natural killer cell recognition of missing self. Nat. Immunol. 9: 477-480.
20. Cohen, G. B., R. T Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
21. Cretney, E., M. A. Degli-Esposti, E. H. Densley, H. E. Farrell, N. J. DavisPoynter, and M. J. Smyth. 1999. m144, a murine cytomegalovirus (MCMV)encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. J. Exp. Med. 190: 435-444.
22. Wang, E. C, B. McSharry, C. Retiere, P. Tomasec, S. Williams, L. K Borysiewicz, V M. Braud, and G. W. Wilkinson. 2002. UL40-mediated NK evasion during productive infection with human cytomegalovirus. Proc. Natl. Acad. Sci. USA 99: 7570-7575.
23. Babic, M., M. Pyzik, B. Zafirova, M. Mitrovic, V Butorac, L. L. Lanier, A. Krmpotic, S. M. Vidal, and S. Jonjic. 2010. Cytomegalovirus immunoevasin reveals the physiological role of "missing self recognition in natural killer cell dependent virus control in vivo. J. Exp. Med. 207: 2663-2673.
24. Fernandez, N. C, E. Treiner, R. E. Vance, A. M. Jamieson, S. Lemieux, and D. H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105: 4416-4423.
25. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713.
26. Bashirova, A. A., R. Thomas, and M. Carrington. 2011. HLA/KIR restraint of HIV: surviving the fittest. Annu. Rev. Immunol. 29: 295-317.
27. Jamil, K. M., and S. I. Khakoo. 2011. KIR/HLA interactions and pathogen immunity. J. Biomed. Biotechnol. 2011: 298348.
28. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
29. Magri, G., A. Muntasell, N. Romo, A. Sáez-Borderías, D. Pende, D. E. Geraghty, H. Hengel, A. Angulo, A. Moretta, and M. López-Botet. 2011. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirusinfected myeloid dendritic cells overcoming viral immune evasion strategies. Blood 117: 848-856.
30. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K. J. Malmberg, J. Klingström, C. Ahlm, and H. G. Ljunggren. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
31. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166: 5034-5043.
32. Xie, X., M. D. Stadnisky, and M. G. Brown. 2009. MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. J. Immunol. 182: 7163-7171.
33. Xie, X., M. D. Stadnisky, E. R. Coats, M. M. Ahmed Rahim, A. Lundgren, W. Xu, A. P. Makrigiannis, and M. G. Brown. 2010. MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus. Proc. Natl. Acad. Sci. USA 107: 8754-8759.
34. Stadnisky, M. D., X. Xie, E. R. Coats, T. N. Bullock, and M. G. Brown. 2011. Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity. Blood 117: 5133-5141.
35. k class I proteins. J. Virol. 81: 229-236.
36. Barao, I., M. Alvarez, E. Ames, M. T. Orr, H. E. Stefanski, B. R. Blazar, L. L. Lanier, S. K. Anderson, D. Redelman, and W. J. Murphy. 2011. Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC. Blood 117: 7032-7041.
37. Depatie, C., A. Chalifour, C. Paré, S. H. Lee, S. M. Vidal, and S. Lemieux. 1999. Assessment of Cmv1 candidates by genetic mapping and in vivo antibody depletion of NK cell subsets. Int. Immunol. 11: 1541-1551.
38. Tay, C. H., L. Y. Yu, V. Kumar, L. Mason, J. R. Ortaldo, and R. M. Welsh. 1999. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J. Immunol. 162: 718-726.
39. Daniels, K. A., G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194: 29-44.
40. Orr, M. T., W. J. Murphy, and L. L. Lanier. 2010. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 11: 321-327.
41. Lundgren, A., S. Kim, M. D. Stadnisky, and M. G. Brown. 2012. Rapid discrimination of MHC class I and killer cell lectin-like receptor allele variants by high-resolution melt analysis. Immunogenetics 64: 633-640.
42. Wheat, R. L., P. Y. Clark, and M. G. Brown. 2003. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J. Virol. Methods 112: 107-113.
43. Wickham, H. 2009. ggplot2: elegant graphics for data analysis. Springer, New York.
44. Wei, T. 2013. corrplot: Visualization of a correlation matrix. R package version 0.71. Available at: http://CRAN.R-project.org/package=corrplot.
45. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57: 289-300.
46. Makrigiannis, A. P., E. Rousselle, and S. K. Anderson. 2004. Independent control of Ly49g alleles: implications for NK cell repertoire selection and tumor cell killing. J. Immunol. 172: 1414-1425.
47. Brodin, P., T. Lakshmikanth, K. Kärre, and P. Höglund. 2012. Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets. J. Immunol. 188: 2218-2226.
48. Jonsson, A. H., L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama. 2010. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184: 3424-3432.
49. Yokoyama, W. M., and B. F. Plougastel. 2003. Immune functions encoded by the natural killer gene complex. Nat. Rev. Immunol. 3: 304-316.
50. Tai, L. H., M. L. Goulet, S. Belanger, N. Toyama-Sorimachi, N. Fodil-Cornu, S. M. Vidal, A. D. Troke, D. W. McVicar, and A. P. Makrigiannis. 2008. Positive regulation of plasmacytoid dendritic cell function via Ly49Q recognition of class I MHC. J. Exp. Med. 205: 3187-3199.
51. Brown, M. G., and A. A. Scalzo. 2008. NK gene complex dynamics and selection for NK cell receptors. Semin. Immunol. 20: 361-368.
52. Genser, B., P. J. Cooper, M. Yazdanbakhsh, M. L. Barreto, and L. C. Rodrigues. 2007. A guide to modern statistical analysis of immunological data. BMC Immunol. 8: 27.
53. Dighe, A., M. Rodriguez, P. Sabastian, X. Xie, M. A. McVoy, and M. G. Brown. 2005. Requisite H2k role in NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J. Immunol. 175: 6820-6828.
54. Stadnisky, M. D., A. Manichaikul, A. G. Lundgren, and M. G. Brown. 2009. NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. Immunogenetics 61: 755-764.
55. Andrews, D. M., L. C. Sullivan, N. Baschuk, C. J. Chan, R. Berry, C. L. Cotterell, J. Lin, H. Halse, S. V. Watt, J. Poursine-Laurent, et al. 2012. Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat. Immunol. 13: 1171-1177.
56. Pessino, A., S. Sivori, C. Bottino, A. Malaspina, L. Morelli, L. Moretta, R. Biassoni, and A. Moretta. 1998. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 188: 953-960.
57. Sivori, S., D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29: 1656-1666.
58. Mavilio, D., J. Benjamin, M. Daucher, G. Lombardo, S. Kottilil, M. A. Planta, E. Marcenaro, C. Bottino, L. Moretta, A. Moretta, and A. S. Fauci. 2003. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc. Natl. Acad. Sci. USA 100: 15011-15016.
59. De Maria, A., M. Fogli, P. Costa, G. Murdaca, F. Puppo, D. Mavilio, A. Moretta, and L. Moretta. 2003. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33: 2410-2418.
60. Wong, A. H., K. Williams, S. Reddy, D. Wilson, J. Giddy, G. Alter, M. Ghebremichael, M. N. Carrington, T. Ndung'u, B. D. Walker, et al. 2010. Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults. AIDS Res. Hum. Retroviruses 26: 459-469.
61. Alter, G., S. Jost, S. Rihn, L. L. Reyor, B. E. Nolan, M. Ghebremichael, R. Bosch, M. Altfeld, and G. M. Lauer. 2011. Reduced frequencies of NKp30+ NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance. J. Hepatol. 55: 278-288.
62. Bozzano, F., P. Costa, G. Passalacqua, F. Dodi, S. Ravera, G. Pagano, G. W. Canonica, L. Moretta, and A. De Maria. 2009. Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. Int. Immunol. 21: 779-791.
63. Krämer, B., C. Körner, M. Kebschull, A. Glässner, M. Eisenhardt, H. D. Nischalke, M. Alexander, T. Sauerbruch, U. Spengler, and J. Nattermann. 2012. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 56: 1201-1213.